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A cDNA containing the entire coding region for human nucleolin has been isolated from a 1 gtl0 human retinal library 
using a bovine cDNA probe. The cDNA hybridized to a transcript of 3000 bases from fast-dividing cells, as well as termi- 
nally differentiated tissues of several species. Translation of the nucleotide sequence revealed a long open reading frame 
which predicts a 707 amino acid protein with several distinct domains. These include repeating elements, four conserved 
RNA-binding regions, a glycine-rich carboxy-terminal domain and sites for phosphorylation, glycosylation and dibasic 
cleavage. Human and bovine nucleolin exhibited more additions and/or substitutions of aspartate, glutamate and serine 
residues in the chromatin-binding domains by comparison with the hamster and mouse nucleolins. These differences may 
be related to species-specific functions in transcription. 
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1. INTRODUCTION 
Nucleolin, also known as C23, is an abundantly 
expressed acidic phosphoprotein of exponentially 
growing cells and has been shown to be mainly 
localized in dense fibrillar regions of the nucleolus 
[ 1,2]. This multifunctional protein [3] was shown 
to be involved in the control of transcription of 
ribosomal RNA genes by RNA polymerase I [4,5], 
in ribosome maturation and assembly [6,7], and in 
the nucleocytoplasmic transportation of ribosomal 
components [S]. The above activities are regulated 
not only by phosphorylation and proteolysis [9], 
but also by basic fibroblast growth factor [lo] and 
by other thus far unidentified cytoplasmic 
regulators of nuclear activities [8]. 
While complete protein sequences for nucleolin 
have been isolated from hamster and mouse 
[ 11,121, the human nucleolin gene has thus far not 
been reported. This deficiency has precluded not 
only analysis of species-specific functions but also 
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analysis of this protein in viral or chemically 
transformed human cells, in which one might an- 
ticipate this protein to have important regulatory 
functions. In the present paper, we describe ex- 
periments leading to our discovery of the human 
nucleolin gene. 
2. MATERIALS AND METHODS 
2.1. Construction of cDNA library from adrenal medulla 
Poly A+ containing RNA from bovine adrenal medulla was 
purified by oligo(dT) column chromatography [13] of the 
guanidine thiocyanate isolated RNA 1141. The cDNA library 
was constructed using 2 ,ug poly A+ according to a previously 
described technique [15]. The cDNA was treated with EcoRI 
methylase and the ends were blunted by the Klenow fragment 
of DNA polymerase I. EcoRI linkers were then added (0.5pg 
linkers//g cDNA) using T4 DNA ligase. After treatment with 
EcoRI, the free linkers were separated from cDNA by 
chromatography on a Bio-Gel A-50m column. 25 ng cDNA 
were ligated to 1 pg EcoRI-cleaved A gtl I. The phages were 
packaged in vitro and were amplified using E. cob strain Y1088. 
2.2. Isolation of bovine and human nucleolin cDNA 
Recombinant proteins expressed by the bovine cDNA library 
were probed with anti-cytochrome b-561 antibody as described 
[16,17], and a 610 bp partial cDNA clone coding for nucleolin 
was isolated. Other libraries (bovine brain library, Clonetech; 
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bovine retinal library, Dr H.G. Khorana; and human retinal 
library, Dr Jeremy Nathans) were screened by plaque hybridiza- 
tion [18] with the bovine nucleolin cDNA, leading to the isola- 
tion of two human clones (CH2, 2.1 kb and CH4, 1.8 kb) and 
a 770 bp bovine clone. The human retinal library was re- 
screened using a 36 bp oligonucleotide (5 ‘-AGCCACACCAG- 
GCAAAGCATTGGTAGCAACTCCT-3’) from the 5’-end of 
CH2 clone. Ten positive phages were isolated from 1 x lo5 pla- 
ques and five contained the same full-length cDNA. 
2.3. Nucleotide sequence analysis 
EcoRI cDNA inserts or fragments generated by restriction 
with HaeIII, RsaI or A/u1 were subcloned into M13mp18 for se- 
quencing using the dideoxy chain termination method [19] with 
Sequenase. Sequence analysis was performed using the 
Microgenie Program of Beckman and secondary structure was 
predicted by the method of Garnier [20] using a computer pro- 
gram obtained from Dr Janet Finer-Moore [Zl]. 
2.4. RNA blot hybridization 
Northern blot analysis was done by separating 5 pg poly A+ 
RNA by electrophoresis on a 1 .O% agarose gel in the presence 
of 2.2 M formaldehyde [22] and by transferring the RNA to a 
Nytran membrane (Schleicher & Schuell). The blots were then 
hybridized and washed according to the manufacturer’s recom- 
mendations. Hybridization probes were prepared by the 
random-primer method [23]. 
2.5. Other reagents 
Restriction endonucleases, T4 DNA ligase, T4 polynucleotide 
kinase, MLV reverse transcriptase, RNase H and DNA 
polymerase I were purchased from either BRL or New England 
Biolabs. Sequenase kits were obtained from United States 
Biochemicals. 
3. RESULTS 
3.1. Determination of the human nucleolin 
sequence 
While screening a bovine adrenal medulla cDNA 
library using antiserum raised against cytochrome 
b-561, a major membrane protein of chromaffin 
cells [24], a clone was isolated which had 90% 
homology to hamster nucleolin [ 111. Several other 
libraries were screened for full-length clones using 
bovine nucleolin cDNA. The largest insert 
(2570 bp) was obtained from a X gtl0 human 
retinal library, which when sequenced turned out 
to be full-length. The complete nucleotide se- 
quence of the cDNA was obtained as illustrated in 
fig.lA and is shown in fig.lB. The clone contains 
a 114 bp 5’-untranslated region and a 2121 bp 
coding region. The initial ATG has a well con- 
served Kozak [25] consensus nucleotide sequence 
needed for translation initiation. The 332 bp 
untranslated region at the 3 ‘-end includes the un- 
usual polyadenylation signal TATAAA at nucleo- 
tide position 2424. 
The open reading frame for human nucleolin 
cDNA codes for a 707 amino acid long protein of 
77 kDa. The amino acid sequence in the coding 
region is 84% and 81% identical to that of hamster 
and mouse nucleolin cDNA, respectively. In addi- 
tion, the sequence has distinct structural features 
such as: (i) highly charged acidic stretches at the 
amino-terminus with characteristic repeats; (ii) 
phosphorylation and glycosylation sites; (iii) 
ribonucleoprotein consensus sequences and (iv) a 
glycine-rich carboxy-terminal sequence. These 
data strongly support our identification of the 
clone as that of human nucleolin. Comparison of 
the amino acid sequences of human nucleolin with 
those of bovine, hamster, mouse and chicken is 
shown in fig.2 and is presented in more detail in 
section 4. 
3.2. Northern analysis of human nucleolin 
Poly A+ RNA was prepared from various types 
of tissues and analyzed for expression of nucleolin 
mRNA by Northern blot. A major band of 
3000 bp was detected in human retina, adrenal 
gland, liver, and a neuroblastoma cell line SK-N- 
SH. Similar results were obtained with bovine 
retina, adrenal medulla, liver, kidney and brain, 
plus rat brain and retina (fig.3). The two lower 
faint hybridizing bands seen in bovine liver and 
kidney could be alternative forms of nucleolin 
mRNA or degradation products. Expression of 
mRNA of the same size in different tissues is con- 
sistent with the notion that nucleolin is a ubi- 
quitous protein involved with the critical processes 
of ribosomal RNA synthesis and subsequent 
ribosome maturation. As previously reported, 
nucleolin was found to be most abundant in ex- 
Fig. 1. (A) Restriction endonuclease map of nucleolin cDNAs and sequencing strategy. The thick line represents the coding region which 
is flanked by 5 ‘- and 3 ’ -noncoding regions indicated by thin lines. The direction of the sequence obtained from CHl, CH2, CH3, CH4 
or restriction fragments using either specific primers (----+) or the universal primers (-) are indicated by arrows. (B) Nucleotide 
and deduced amino acid sequence of the human nucleolin cDNA insert. Numbers for the nucleotides and amino acids are placed above 
or below their respective sequences. The presumed polyadenylation signal near the 3’-end is underlined. 
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Fig.2. Comparison of the amino acid sequences of human and bovine nucleolin with hamster, mouse and chicken. Hu, human 
nucleolin; Ha, hamster nucleolin; MO, mouse nucleolin; Bo, bovine nucleolin; Ch, chicken nucleolin. The numbering of the amino 
acids of human nucleolin is indicated above the single letter code (top sequence). Amino acids in the other protein sequences which 
are identical to human nucleolin are indicated by dashes and the amino acids which are different are denoted by single letters. 
Circumflexes indicate spaces introduced into the sequences for better alignment. Asterisks above the human sequence indicate potential 
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Fig..?. Northern blot analysis of nucleolin mRNA from 
different tissues. 5 fig from various tissues were analyzed. (SK- 
N-SH) Human neuroblastoma cell line; (BL) bovine liver; (BK) 
bovine kidney; (BB) bovine brain; (RB) rat brain; (RR) rat 
retina; (HA) human adrenal; (HR) human retina; (HL) human 
liver; (BR) bovine retina; (BA) bovine adrenal. 
ponentially growing cells such as the neuroblas- 
toma SK-N-SH. However, nucleolin synthesis was 
considerable in tissues containing nondividing cells 
such as retina, adrenal medulla and brain. 
4. DISCUSSION 
4.1. Analysis of human nucleolin sequence 
A full-length human nucleolin cDNA from a 
retinal library was isolated using a bovine nucleolin 
partial cDNA. The 5 ‘-untranslated region of 
114 bp in human is approximately 50% different 
from hamster and mouse sequences. The first 105 
nucleotides in the 3 ’ -untranslated region of human 
nucleolin have a striking similarity (85%) to 
hamster and mouse, while the remainder of the 
nucleotides show considerable variation by 38% 
and 50%) respectively. As expected, the coding se- 
quences for nucleolin in several species are highly 
conserved. 
4.2. Nucleolin structure and function 
We have observed that nucleolin has seventeen 
very conserved dibasic cleavage sites (15, 51, 54, 
62, 70, 79, 87, 95, 109, 124, 141, 219, 279, 281, 
294, 387, and 702). These could be the processing 
signals giving rise to different nucleolar proteins 
and possibly to other, as yet unidentified, 
biologically active peptides. Furthermore, human 
nucleolin has an additional site at position 545. 
The presence of potential dibasic cleavage sites for 
proteolytic processing has been observed in the 
case of chromogranin A [26] and some prohor- 
mones [27]. Nucleolin is highly susceptible to pro- 
teolytic degradation [28]. Polypeptides with 
masses of 95, 76, 70, 60 and 50 kDa have been 
identified with specific antisera to the 100 kDa 
protein, and it was suggested that these presumed 
nucleolin fragments resulted from thiol protease 
cleavage of the 100 kDa molecule [29]. It would be 
interesting to investigate which dibasic cleavage 
sites actually are utilized in vivo. 
Recent reports suggest hat karyophilic signals 
present in the proteins may be responsible for 
transporting cytoplasmic ribosomal components 
into the nucleolus [8,30]. The conserved, repeated 
sequence [TP(GAV)KK(GAV)2] at positions 59, 
76, 84,92, 106 and 121 could be putative nucleolar 
localization signals. These sequences contain a 
hydroxy amino acid, a proline, and paired dibasic 
residues, all of which are found in nuclear localiza- 
tion signals [31,32]. 
Other regions rich in aspartate and glutamate 
(positions 143-169, 184-209, and 234-272) are 
thought to be involved in binding to histones [33] 
and show variation between species. In the first 
segment, a potential phosphorylation site is 
displaced 5 residues toward the N-terminus of the 
human gene. In the second acidic segment, the 
phosphorylation site is abolished only in the 
bovine, which also has five additional glutamate 
residues relative to the rodent and human proteins. 
In the third acidic segment, the number of acidic 
amino acids is greatest in bovine (44), followed by 
human (39), hamster (34), mouse (34) and 
Xenopus (20). Most notably, in all three segments 
the substitutions and additions are only with aspar- 
tate or glutamate and occasionally with serine. In 
between the first two acidic segments, the human 
sequence exhibits both a deletion and high 
variability when compared to the hamster and 
mouse sequences. Conserved phosphorylation sites 
are located at position 28, 34, 145, 498, 580, 584 
and 619. The variation in the number of acidic 
amino acids and in the location of phosphorylation 
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sites could be related to species specificity in the 
control of rRNA transcription [34], or to cation 
binding which could affect the specificity of 
phosphoprotein kinases [35]. Experiments involv- 
ing deletion and mutation of the acidic domains 
might clarify the specific roles of these regions. 
The four RNA-binding domains (positions 
324-319, 406-461, 498-553 and 588-643) con- 
taining the central consensus equences are present 
in human nucleolin. The fourth domain has the 
greatest conservation of sequence between species 
as recently reported in a comparison of the rodent 
and Xenopus sequences [36]. A glycine-rich 
carboxy-terminal domain (position 648-703) is 
also conserved and may be involved in protein- 
protein and/or protein-nucleic acid interactions 
[37]. The three additional glycine residues after 
position 695 seem specific for hamster nucleolin 
and 2 additional glycines after position 677 seem 
specific for chicken. Two conserved glycosylation 
sites are observed at position 317 and 492. The 
glycosylation sites at position 399 and 403, 
previously observed in hamster and mouse, are not 
detected in either human or bovine, and the 
glycosylation site at 478 is present in human and 
hamster, but not in mouse and chicken. We report 
an additional glycosylation site at position 541. 
We also compared the predicted secondary 
structures for the human, hamster, and mouse 
nucleolin amino acid sequences. All three 
predicted structures were almost identical with 
more than 60% helix predicted for each protein. 
Even where the human sequence differed with the 
mouse or hamster, such as residues 401-405 and 
470-474, the predicted secondary structures were 
essentially identical. Significant lengths of 
predicted a-helix were found in all regions of the 
protein except the glycine-rich carboxy-terminal 
region. Very large probabilities of a-helix forma- 
tion were observed immediately on either side of 
the four consensus equences (positions 344-354, 
426-436, 520-530 and 607-617) of RNA binding. 
These predicted helix structures were approximate- 
ly lo-15 residues in length. The consensus se- 
quences themselves are predicted to have 
&structures with low probability. Thus, it appears 
that a variation of the helix-turn-helix motif may 
be present in each of the four RNA-binding 
segments. A number of DNA-binding proteins 
with known structure exhibit a helix-turn-helix seg- 
104 
ment which interacts with the DNA [38]. In the 
case of nucleolin the turn segments (containing the 
consensus sequences) are between 10 and 20 
residues in length which is larger than in the DNA- 
binding proteins. Although the mode of interac- 
tion in this region of nucleolin with RNA may be 
different than the interaction of DNA-binding pro- 
teins with double-stranded DNA, it is possible that 
the structural motif of a helix-turn-helix in various 
proteins has been adapted for binding to both 
types of polynucleotide. 
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